Hematopoietic Stem Cell Transplant in primary immunodeficiencies
Recommended Indications in which IG can be used
Order Number: I3-HSCTPID
| Recommendations | IVIG is recommended in PID patients undergoing stem cell transplant. |
| Dose/Frequency of Administration | 0.4 to 0.6 g/kg every 3-4 weeks; requirements may increase and should be based on clinical outcome. |